INTRODUCTION
Complex-type N-glycans present on the cell surface are necessary for cellular interactions (Yoshimura et al., 1995b; Guo et al., 2001; Zhang et al., 2004) . Changes in the amount and composition of complex-type structures have been frequently observed in the transformation and progression of different types of tumors (Laidler & Lityńska, 1997; Taniguchi & Korekane, 2011) , including melanoma (Pocheć et al., 2003; Przybyło et al., 2007; Pocheć et al., 2013) . The increase in the size of N-glycans is the result of increased branching of complex-type structures (Kim & Varki, 1997; Karaçali et al., 2014) . One of the most commonly observed changes in the glycosylation profile of tumor cells is an enhanced synthesis of the antenna linked β1,6 to the core structure of N-glycans (Dennis et al., 1987; Lityńska et al., 2008) . It has been shown that β1,6-branching is inhibited when bisected N-acetylglucosamine (GlcNAc) is added to the complex-type structures during the previous step of oligosaccharide processing pathway (Zhao et al., 2006) . The key factor that determines the structure of the complex-type N-glycans is cell-specific expression of Golgi glycosyltransferases (Taniguchi & Korekane, 2011) . The formation of β1,6-branching in N-glycans is catalyzed by β1,6-N-acetylglucosaminyltransferase V (GnT-V) encoded by MGAT5 gene, while bisected GlcNAc is bound to the core structure by β1,4-Nacetylglucosaminyltransferase III (GnT-III) encoded by MGAT3 gene (Taniguchi et al., 1996) . The expressions of GnT-III and GnT-V and their products are strongly associated with carcinogenesis (Taniguchi et al., 1999) , and therefore the altered expression of glycosyltranferases is extensively investigated in the human surgery resected sections and in vitro models for use as prognostic markers in cancer diagnosis.
Although uveal (UM) and cutaneous (CM) melanoma cells derive from the transformed melanocytes, their biological properties vary significantly in several aspects (ten Berge et al., 1994; Jovanovic et al., 2013) . The development of UM and CM has a different genetic background; about 50% of CM have functional mutations in BRAF gene that activate Ras-Raf-MEK-ERK pathway, whereas in UM cells this mutation was not found (Belmar-Lopez et al., 2008; Shtivelman et al., 2014) . In turn, ocular melanoma cells are characterized by mutations in GNAQ and GNA11 genes, encoding the α-subunit of G protein (Nikolaou et al., 2012) . UM and CM progression also differs remarkably; the well-defined stages of progression can be distinguished in CM in contrast to UM (Seftor et al., 1999; Chudnovsky et al., 2005) . Additionally, CM and UM melanoma cells metastasize preferentially to various organs, due to different ways of dissemination (Folberg, 1993; van den Bosch et al., 2010) .
Our group has investigated the glycosylation profiles of melanoma cells for over fifteen years. We have clearly demonstrated that the glycosylation profile of adhesion proteins (mainly integrins) depends on the stage of tumor development (Pocheć et al., 2003 , Przybyło et al., 2007 Pocheć et al., 2013) and the location of metastasis Janik et al., 2010) . Here we searched for the reasons of a different behavior of UM and CM cells in the surface glycosylation. The present study was designed to compare the expression of GnT-III and GnT-V enzymes and their products in primary melanoma cells of different origin, uveal vs. cutaneous. The results of the previous studies have suggested that the increase in β1,6-branching begins in the early stage of oncogenic transformation (Demetriou et al., 1995; Ito et al., 2001; Pocheć et al., 2015) . Our study showed that UM cells are more abundant in β1,6-branched glycans than CM cells and this results from a higher expression of MGAT5 gene.
MATERIALS AND METHODS
Cell lines and reagents. Primary human melanoma cell lines, two cutaneous (FM-55-P, IGR-39) and two uveal (92-1, mel-202) (89900) and PageRuler Prestained Protein Ladder (26616) were ordered from Thermo Scientific (Carlsbad, CA, USA). Laemmli sample buffer (LSB, 161-0737) and β-mercaptoethanol (161-0710) were procured from Bio-Rad (Hercules, CA, USA). Substrates for alkaline phosphatase (AP), 5-bromo,4-chloro,3-indolyphosphate (BCIP, 11383221001) and nitroblue tetrazolium (NBT, 11383213001) were from Roche (Mannheim, Germany).
Cell culture and cell lysate preparation. Melanoma cells were cultured in RPMI1640 with 10% FBS and antibiotics (100 U/ml penicillin, 100 μg/ml streptomycin) at 37°C in 5% CO 2 humid atmosphere (CO 2 incubator, Lab Line Instruments). The cells were lysed in RIPA buffer containing protease inhibitors. The lysates were centrifuged (15 000 rpm) for 20 min at 4°C and the protein concentration was measured in the collected supernatants using the Total Protein Kit (Micro Lowry, Peterson's Modification) and BSA as a standard.
Real-time PCR. MGAT3 and MGAT5 expressions were analyzed quantitatively using real-time PCR (qRT-PCR). RNA was extracted using RNeasy Protect Mini Kit and cDNA was synthesized in reverse transcription using the Omniscript RT Kit according to the manufacturer's protocols. qRT-PCR was performed as described previously (Bubka et al., 2014) with minor modification. To assess the expression of MGAT3 and MGAT5 genes the values of Ct (cycle threshold) were normalized to the expression level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) used as an endogenous control according to the equation: ∆Ct = Ct tested gene -Ct endogenous control Sequence of GAPDH primers were as follows, forward: 5′-CAGCCTCAAGATCATCAGCA-3′, reverse: 5′-GTCTTCTGGGTGGCAGTGAT-3′.
Western blotting. GnT-III and GnT-V expression was analyzed by Western blotting. Thirty µg of total cell lysate protein were boiled in LSB with 5% β-mercaptoethanol for 5 min, separated on 8% SDS/PAGE gel, transferred to a polyvinylidene difluoride membrane (PVDF), and detected using the monoclonal antibodies. After overnight blocking in 1% BSA in TBST, the membranes were incubated for 1 h at RT with mouse anti-GnT-III, mouse anti-GnT-V and rabbit anti-GAP-DH antibodies diluted 1:100 (anti-GnT-III, anti-GnT-V) or 1:4000 (anti-GAPDH) in 1% BSA in TBST. Then, AP-conjugated goat anti-mouse IgG was applied in a 1:4000 dilution, followed by incubation at RT for 1 h. Tested enzymes and GAPDH as an endogenous control were visualized by colorimetric reaction using BCIP and NBT substrates for AP. HMW protein markers were used to calculate the relative molecular weights of GnT-III and GnT-V. Band intensities were measured densitometrically in relation to GAPDH in UVImap analysis software (UVItec, Cambridge, UK).
Lectin blotting. The expression of complex-type N-glycans with bisecting GlcNAc and β1,6-branched was detected using biotinylated PHA-E and PHA-L lectins, respectively. Protein extracts (10 µg) were SDS/PAGE separated on 8% gels and electroblotted. The PVDF membranes were blocked with Carbo-Free blocking solution in TBS (50 mM Tris/HCl, pH 7.5, 150 mM NaCl) overnight at 4°C to prevent non-specific binding of lectins. Then, the membranes were probed with PHA-E and PHA-L lectins (1:4000, in TBS containing 1 mM MgCl 2 , 1 mM CaCl 2 and 1 mM MnCl 2 ) for 1 h at RT followed by incubation with streptavidin-conjugated AP (1:4000, in TBS) for 1 h at RT. Glycans-bound lectins were detected by AP colorimetric reaction.
Fluorescent staining. The cells were cultured on coverslips placed in 4-well plates overnight. Before staining, the cells were washed three times with PBS, fixed in 2% paraformaldehyde for 10 min at RT and incubated with FITC-conjugated PHA-E and PHA-L lectins (diluted 1:100 in 2% BSA in PBS) overnight at RT. The excess of lectins was removed by washing with PBS, the slides were mounted with Vectashield with DAPI and the coverslips were sealed. Images were captured in a Zeiss confocal microscope (LSM 510) and analyzed in LSM Image Browser (Carl Zeiss MicroImaging GmbH, Germany).
Statistical analysis. The results are represented as means of three measurement ± standard deviation (S.D.). Duncan test was used to determine statistical significance (*p < 0.05) between samples of melanoma cells.
RESULTS

The expression of GnT-V is higher in UM
The expression of GnT-III and GnT-V was analyzed on gene and protein levels. To determine MGAT3 and MGAT5 expression, RNA isolated from melanoma cells was subjected to real-time PCR and the relative abundance of transcripts was assessed using GAPDH as a reference gene. Our data showed that both 92-1 and mel-202 UM cells expressed more transcript for GnT-V than FM-55-P and IGR-39 CM cells. The level of MGAT3 transcript was lower than MGAT5 in all ana-lyzed cell lines, but we did not observe any differences related to the origin of melanomas (Fig. 1) .
Immunoblot analysis of GnT-III and GnT-V expression on protein level showed a difference related to melanoma origin in the case of the second enzyme. The higher content of GnT-V protein in 92-1 and mel-202 UM cell lines (Fig. 2B ) resulted probably from a higher transcription of MGAT5 gene. We observed three isoforms of GnT-III enzyme with different molecular weights, 92, 76 and 70 kDa. The significantly highest expression of two 92 and 76 kDa GnT-III isoforms was noticed in IGR-39 cutaneous cells. The study did not reveal any relationship between GnT-III expression and the location of melanoma origin ( Fig. 2A) .
GlcNAc β1,6-branched N-glycans are more abundant in UM
PHA-E and PHA-L lectins specifically recognizing structures with bisecting GlcNAc and β1,6-branched complex-type glycans, respectively, were used to detect these products of GnT-III and GnT-V catalytic activities. We have applied two methods for the detection of signals from glycoprotein-bound lectins, AP-based colorimetric reaction in lectin blotting and fluorescence detection in confocal microscopy. Lectin blotting studies showed that PHA-E was bound to bisecting GlcNAc bearing glycoproteins ranging from 40 to 200 kDa, while PHA-L staining of β1,6-branched glycoproteins was observed within the whole range of used molecular weight standards. PHA-E-binding glycoprotein pattern was similar for both CM cell lines, while the intensity of PHA-E staining differed within tested UM cells and the glycoprotein pattern recognized by this lectin varied significantly between UM and CM cells (Fig. 3A) . What is interesting, 92-1 cells showed the highest expression of N-glycans with bisecting GlcNAc (Fig. 3A) and the highest expression of MGAT3 among all cells tested (Fig. 1) , but not the expression of GnT-III at protein level ( Fig. 2A) . The amount of β1,6-branched N-glycans was proportionally higher in UM cells than in CM cells (Fig. 3B) and it was consistent with the higher expression of MGAT5 gene ( Fig. 1) and GnT-V protein (Fig. 2B ). Lectin fluorescence in confocal microscopy studies confirmed the differences in glycan expression levels obtained in lectin blotting (Fig. 4) .
DISCUSSION
Many previous studies have shown that glycosylation affects intracellular interactions and contact with ECM proteins (Gu et al., 2012; Christiansen et al., 2014 ) via regulation of signaling pathways (Zhao et al., 2008) . Differences in the glycan structure may contribute to functional dissimilarity of melanoma cells from eye and skin despite both types of melanomas develop from the same type of cells. Our previous study, performed on the same set of uveal and cutaneous melanoma cell lines, demonstrated different adhesion and migration abilities of UM and CM cells. Cutaneous cells bound strongly to FN , vitronectin , collagen (COL) and laminin (LN) (Laidler et al., 2006) , but migrated poorly on FN in comparison to uveal cells. Swainsonine Protein extracts (30 µg) were SDS/PAGE separated on 8% gel in reducing conditions, electroblotted and probed with monoclonal antibodies against GnT-III and GnT-V. After incubation with AP-conjugated anti-mouse IgG, the bands corresponding to GnT-III and GnT-V enzymes were visualized by colorimetric reaction and the intensity of bands was measured densitometrically. CM, cutaneous melanoma; UM, uveal melanoma; HMW, High Molecular Weight Markers (Sigma-Aldrich, SDS6H).
that reduces formation of complex-type glycans, including β1,6-branched ones, affected more efficiently uveal than cutaneous cell migration on FN . We assume that even though surface glycans are not the only one, they are an important element influencing the differences in cell migration on FN. Here we present the characterization of complex-type N-glycans β1,6-branched and with bisecting GlcNAc in melanoma cells derived from primary tumors of ocular and cutaneous origins. Our analysis showed a significantly higher expression of GnT-V enzyme (Figs. 1, 2B ) and its products (Figs. 3B, 4B ) in UM in comparison to CM. GnT-V is an enzyme that is the most strongly associated with cancer progression and metastasis of other glycosyltransferases involved in creation of multi-antennary N-glycans (Miyoshi et al., 2012) . Results of many previous studies showed that the amount of β1,6-branched glycans increases with progression of various cancers (Taniguchi et al., 1999) and promotes metastasis (Couldrey & Green, 2000) . Immunohistochemical analysis of over hundred human colorectal cancer cases surgically resected showed that the expression of GnT-V correlated with metastasis of this cancer (Murata et al., 2000) . Also other immunohistochemical studies performed on clinical samples collected postoperatively provided the evidence for positive correlation between GnT-V level and metastatic potential of gastric cancers (Tian et al., 2008; Huang et al., 2014) , endometrial cancer (Yamamoto et al., 2007) and mucinous ovarian cancers (Takahashi et al., 2009) . On the other hand, there is a group of cancers that shows a favorable prognosis when the expression of GnT-V is higher. This inversely proportional relationship was observed in tissue sections of oral squamous cell carcinoma (Seto et al., 2013) , neuroblastoma , bladder cancers (Ishimura et al., 2006) , non-small cell lung cancers (Dosaka-Akita et al., 2004) and testicular germ Cells growing on coverslips were fixed in 2% paraformaldehyde, incubated with FITC-conjugated PHA-E for detection of bisecting GlcNAc bearing glycans (A) and FITC-conjugated PHA-L for detection of β1,6-branched glycans (B) and lectin staining (green) was visualized in a Zeiss LSM 510 META confocal microscope. DAPI was used to stain cell nuclei (blue). Scale bar -100 mm cell tumors (Kyan et al., 2008) . In view of above data, using GnT-V expression level as a prognostic marker seems to be promising, but cancer-specific. To the best of our knowledge, GnT-V expression was not analyzed in clinical section of melanoma tumors, but it has been studied on in vitro models. Positive correlation between the expression of GnT-V and its products vs. melanoma progression was shown in our previous studies for cell lines derived from vertical growth phase and metastatic lesion of the same patients (Pocheć et al., 2013) . Here we proved that the expression of GnT-V and its products at the early stage of melanoma progression is also dependant on the origin of melanoma.
Our present study did not show any correlation between the expression of GnT-III (Fig. 1, 2A) and N-glycans with bisecting GlcNAc (Fig. 3A, 4A ) with respect to the place of melanoma origin. The expression of GnT-III was demonstrated frequently in chemically induced tumors in animal models (Narasimhan et al., 1988) and in cancer cell lines (Bubka et al., 2014) . But the number of clinical data on the relationship between GnT-III and cancer progression is much lower than those describing GnT-V expression in cancers. The elevated level of GnT-III was observed in sera of patients with hepatomas and liver cirrhosis (Ishibashi et al., 1989) , while the activity of GnT-III was increased in patients with two hematological cancers, myelogenous leukemia and multiple myeloma (Yoshimura et al., 1995a) . Based on the studies on animal and cell line models it is known that GnT-III and its products have a suppressive effect on tumor progression (Isaji et al., 2010) . The transfection of cDNA encoding GnT-III to highly metastatic subclone of B16-F1 murine melanoma cell line exhibited a higher expression of GnT-V products resulted in the reduced invasion into Matrigel and weakened adhesion to COL and LN. The injection of GnT-III-transfected melanoma cells into nude mice suppressed lung metastasis (Yoshimura et al., 1995b) . The ability to reduce cancer by GnT-III was confirmed in several further studies on different models, among them through intracellular pathways induced by epidermal growth factor receptor excessively modified by overexpressed GnT-III (Gu et al., 2009) . In our study, the glycosylation pattern obtained for bisecting GlcNAc glycans was quite different from β1,6-branching (Fig. 3) , indicating that different proteins are substrates for GnT-III and GnT-V and/or the proteins are modified by these enzymes with various intensity. What is important, both CM cells displayed the higher expression of bisecting GlcNAc than β1,6-branched glycans though the reaction with PHA-E was observed in a less narrow range of molecular weight markers than PHA-L (Fig. 3) . Taking into account suppressive properties of GnT-III action, the higher expression of bisected GlcNAc on CM glycoproteins may contribute to their lower ability to migrate on FN and stronger binding to ECM proteins than in case of UM cells showed in our previous studies (Laidler et al., 2006; Janik et al., 2014) .
Determining glycosylation pattern and searching for features specific for melanoma cells of different origins is a crucial stage in understanding biology of melanoma and a reason for differences in the development and progression of UM and CM. The higher level of GnT-V and β1,6-branched glycans in UM than CM cells may be one of the reasons for lower adhesion and higher migration exhibited by UM cells.
